Related Experiment Video
Updated: Feb 21, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Invasive Paget Disease of the Vulva
Objective:
Extramammary Paget disease of the vulva (EPDV) is a rare occurrence with an indolent and relapsing course. Progression to invasion occurs in 4% to 19% of cases. The aim of this study is to report clinical-pathological features and outcomes of patients treated for invasive EPDV.
Methods:
Data of consecutive patients treated between 2000 and 2017 for invasive EPDV were reviewed.
Results:
Among 79 patients with EPDV, 10 (12.7%) presented a microinvasive or invasive form at first diagnosis or during follow-up. All of them underwent upfront radical surgery; 7 (70%) received subsequent radiotherapy, chemotherapy, or both. The mortality rate was 40%. The recurrence rate after treatment for invasive forms was 60%, with a mean time to first recurrence of 20 (range, 5-36) months.
Conclusions:
Our study confirms that invasive EPDV remains a rare gynecological neoplasm with a poor prognosis. Multicentre trials or well-organized prospective data collection could improve the knowledge about the management of invasive EPDV.
Insights
Invasive extramammary Paget disease of the vulva (EPDV) is rare but aggressive. This study found a high mortality (40%) and recurrence rate (60%) in patients with invasive EPDV.
Area of Science:
- Gynecologic Oncology
- Dermatopathology
Background:
- Extramammary Paget disease of the vulva (EPDV) is a rare condition with a typically indolent and relapsing course.
- Progression to invasive disease occurs in a significant minority of cases (4-19%).
Purpose of the Study:
- To report the clinical-pathological features and outcomes of patients treated for invasive EPDV.
- To highlight the challenges in managing this rare but aggressive gynecological neoplasm.
Main Methods:
- Retrospective review of consecutive patients treated for invasive EPDV between 2000 and 2017.
- Analysis of clinical data, treatment modalities, and patient outcomes.
Main Results:
- Out of 79 EPDV patients, 10 (12.7%) had invasive disease at diagnosis or follow-up.
- The mortality rate was 40%, and the recurrence rate after treatment was 60%, with a median time to recurrence of 20 months.
- All patients underwent radical surgery, and 70% received adjuvant radiotherapy, chemotherapy, or both.
Conclusions:
- Invasive EPDV is a rare gynecological neoplasm with a poor prognosis.
- Multicenter trials and prospective data collection are needed to improve understanding and management strategies for invasive EPDV.
More Related Videos
03:49Anogenital Distance and Perineal Measurements of the Pelvic Organ Prolapse POP Quantification System
Published on: September 20, 2018
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
Related Concept Videos
Cancer Cell Migration through Invadopodia
Disorders of the Female Reproductive System
External Female Genitals
Mitral Valve Prolapse III: Nursing Management
Vagina
Abnormal Proliferation